Letter From Concerned Physicians - Antibiotic

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
162
Letter From Concerned Physicians - Antibiotic Resistance

List of doctors in the link>>>

http://homeopathyusa.org/about-aih-2/position...tance.html

America and the world face a crisis.

It is now estimated that antibiotic resistant infections may kill an estimated 10 million people a year and cost the world’s economies some $100 trillion annually1 by the year 2050. Dr. Margaret Chan of the World Health Organization has recently stated that Earth may be approaching a time “when things as common as strep throat or a child’s scratched knee could once again kill.”

Solutions to this looming crisis must be found and found quickly. As some of America’s leading integrative medicine specialists, we believe it is time to look anew at a modality called homeopathic medicine.

Why homeopathic medicine?

As physicians, we are the first to acknowledge that the diagnostic and surgical tools of conventional medicine are scientific marvels - truly extraordinary and life saving. However, it is also a well-documented fact that many of the drugs currently used by conventional medicine carry risks that are often unacceptable, and in the case of bacterial infections – increasingly ineffective.

Signatories, and tens of thousands of our medical colleagues around the world, have repeatedly used homeopathic medicine to effectively and safely treat patients with a wide range of ailments, including serious, and in some cases, life threatening bacterial and viral infections, without the risk of creating further drug resistant organisms. We reached our decision to employ these medicines after careful experimentation and observation, in search of a drug system that relieved suffering without potential toxic side and after-effects.

Why are we recommending consideration of homeopathic medicine?

Let’s start by looking at what we know about it today.

Homeopathic medicine is a 200-year-old system of medicine used by an estimated 500 million people worldwide2. The system relies on medicines made from individual plants, animals and minerals that are serially diluted and vigorously agitated during the manufacturing process. Twelve independent research laboratories in North America, Russia, Europe and Asia have now confirmed that all classically-prepared homeopathic medicines studied contain various nanostructures, including source and silica nanoparticles which are heterogeneously dispersed in colloidal solution 3 4 5 6. The above mentioned laboratories and others have found that homeopathic medicines, like modern engineered nanoparticles, have been found to act by modulating biological function of the allostatic stress response network, including cytokines, oxidative stress and heat shock proteins 7,8. Additionally, there are hundreds of peer-reviewed studies including randomly controlled trials and large observational studies on individual cells, plants, animals and humans, that show homeopathic medicines are exceptionally safe and have measurable and positive biological and therapeutic effects9.

Reliable and extensive clinical and public health records have also been carefully examined internationally, looking for evidence of homeopathic medicine’s efficacy during some of the deadliest epidemics of the past 200 years. The main findings of this research show that when homeopathic medicine was employed during these deadly events, mortality rates were routinely very low. This constancy remained regardless of the homeopathic physician, time, place or type of epidemical disease, including diseases carrying a high mortality rate, such as cholera, smallpox, diphtheria, typhoid fever, yellow fever, influenza and pneumonia10.

Some in the medical community will have reservations about exploring the potential of homeopathic medicine to treat dangerous bacterial infections and will base their objections on two factors: (1) the idea that homeopathic medicines at potencies above 12C contain no active ingredients and, (2) a study published by Shang, et. al. in 2005.

As stated earlier – nanoscientists at 12 independent research labs have now consistently confirmed that all medicines studied contain various nanostructures, including source and silica nanoparticles which are heterogeneously dispersed in colloidal solution – making homeopathic medicine the first known form of nanomedicine. What’s more – we now know from recent discoveries in nanoscience that each remedy manufactured using traditional methods of trituration and vigorous agitation must in fact contain nanostructures. As for the Shang study – it has been repeatedly invalidated by a number of medical researchers as methodologically flawed even within an allopathic medical framework11,12,13,14,15.

Finally – we make this recommendation while knowing that many of our colleagues will feel uncomfortable using homeopathic medicine singly. As a result – we are calling for a collaborative effort to investigate the efficacy of homeopathic medicine in the treatment of patients with these increasingly dangerous infections whereby homeopathic medicine is used only as an adjunct to conventional therapies.

All physicians are bound together by a passion to serve the sick and not by a blind allegiance to any class of drug makers. In the interest of enhancing care, we must set aside tribal divisions that began in the 1840s and come together in unbiased fashion to find solutions to meet the rising tide of antibiotic resistant bacteria that may, in short order, threaten the lives of millions annually.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Nuix Leverages AI for Transformative Legal Review

Updated Category News Views 1

Nuix Unveils AI Innovations in Legal Review Diving headfirst into the evolving world of legal technology, Nuix has just rolled out some serious upgrades to its eDiscovery toolkit. By plucking AI right out of the data science ethers, they're not just dabbling in futuristic tech—they're planting generative AI at the heart of legal review on their SaaS platform, Nuix...

Continue Reading
Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Updated Category News Views 3

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Continue Reading
Hims & Hers Faces Class Action: Investors Beware

Updated Category News Views 2

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Continue Reading
Midea's VitaBreeze: Revolutionizing Personalized Climate

Updated Category News Views 6

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop

Updated Category News Views 2

EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...

Continue Reading
Global Movement Urges Dr. Hak Ja Han's Release

Updated Category News Views 3

Under the shadows of Manhattan's skyline, something more than a regular service took shape. The New Yorker Hotel hosted an impassioned gathering of the Family Federation for World Peace and Unification. These folks weren't just saying their prayers; they were making a call—loud and resonant—for the release of Dr. Hak Ja Han. The Power of Collective Voices Gathering in...

Continue Reading
53% of European Telecom Users Eye Provider Switch

Updated Category News Views 0

Change Is Brewing in Europe's Telecom Markets Seems like Europe's telco scene is simmering. Over half of consumers in major European markets are giving their mobile providers the side-eye, ready to jump ship. That's putting the heat on operators who once banked on loyalty programs to keep their customer base intact. Diverse Loyalty Challenges Across Europe What's...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 2

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading

Top 5 Most Recently Viewed Articles

Financial Planner Christopher Krell Honored: A Career Defined

Updated Category News Views 21

From Humble Beginnings to Industry Stardom Christopher Krell isn't your average financial planner. This guy’s been riding the financial tides like a seasoned mariner since back in '97. If you’re catching wind of his accolades from the likes of Forbes and The Financial Times, it’s no surprise. The man grew up with finance in his DNA. Pops was all about those...

Continue Reading
Insightful Look at Knightscope Inc's Growing Short Interest

Updated Category News Views 132

Understanding Short Interest in Knightscope Inc Knightscope Inc's (NYSE: KSCP) short interest has seen a notable increase of 28.13% since the last reporting period. Currently, approximately 1.06 million shares have been sold short, equating to about 10.84% of all available shares in the market. This uptick suggests a significant shift in trader sentiment, highlighting the...

Continue Reading
TerraPower Expands HALEU Production Partnership with ASP Isotopes

Updated Category News Views 204

TerraPower Forms Strategic Alliance for HALEU Production TerraPower, an innovative leader in nuclear energy development, has made a significant move to bolster the global supply of high-assay low-enriched uranium (HALEU). The company has officially sealed a term sheet with ASP Isotopes Inc., marking a vital step in expanding its HALEU production capabilities. This...

Continue Reading
MRC Global Prepares for Q3 2024 Earnings Call and Webcast

Updated Category News Views 57

MRC Global Gears Up for Q3 Earnings Announcement MRC Global Inc. is preparing to announce its results for the third quarter of 2024 soon. This eagerly awaited release will occur in November, giving investors vital information about the company’s performance. Details of the Conference Call MRC Global will also hold a significant conference call and webcast right...

Continue Reading
Japan's Bond Market Struggles with BOJ's Withdrawal Impact

Updated Category News Views 169

Challenges in Japan's Bond Market Amid BOJ's Strategy Shift Japan's robust bond market, valued at approximately $9 trillion, is currently facing significant strain as a result of the Bank of Japan's (BOJ) extensive bond-buying program. This initiative has led to a critical shortage of available bonds, which is beginning to disrupt the settlement processes for various...

Continue Reading